Optical Coherence Tomographic Pattern May Predict Visual Outcome after Intravitreal Triamcinolone for Diabetic Macular Edema

Ophthalmology

Volumn 114, Issue 5, 2007, Pages 890-894

  Gibran, S K ^a   Khan, K ^a   Jungkim, S ^b   Cleary, P E ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; TRIAMCINOLONE ACETONIDE;

AGED; ARTICLE; CONTROLLED STUDY; COUNSELING; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EYE; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA; RETINA MACULA DEGENERATION; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; THICKNESS; TREATMENT FAILURE; VISION; VISUAL ACUITY; VISUAL SYSTEM;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA, CYSTOID; MALE; PROSPECTIVE STUDIES; RETINA; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TRIAMCINOLONE; VISUAL ACUITY; VITREOUS BODY;

EID: 34247501772     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.11.026     Document Type: Article

References (12)

1. Jonas J.B., Kreissig I., Sofker A., and Degenring R.F. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121 (2003) 57-61
2. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
3. Lai W.W., Mohamed S., and Lam D.S. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy. [letter]. Ophthalmologica 219 (2005) 189
4. Recchia F.M., Ruby A.J., and Carvalho Recchia C.A. Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema. Am J Ophthalmol 139 (2005) 447-454
5. Hee M.R., Puliafito C.A., Wong C., et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 113 (1995) 1019-1029
6. Micelli Ferrari T., Sborgia L., Furino C., et al. Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema. Eur J Ophthalmol 14 (2004) 321-324
7. Massin P., Audren F., Haouchine B., et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Preliminary results of a prospective controlled trial. Ophthalmology 111 (2004) 218-224
8. Hee M.R., Izatt J.A., Swanson E.A., et al. Optical coherence tomography of the human retina. Arch Ophthalmol 113 (1995) 325-332
9. Puliafito C.A., Hee M.R., Lin C.P., et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 102 (1995) 217-229
10. Hee M.R., Puliafito C.A., Duker J.S., et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105 (1998) 360-370
11. Otani T., Kishi S., and Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127 (1999) 688-693
12. Browning D.J., and Fraser C.M. Regional patterns of sight-threatening diabetic macular edema. Am J Ophthalmol 140 (2005) 117-124